Ralliant Corporation (NYSE:RAL) Sees Large Decline in Short Interest

Ralliant Corporation (NYSE:RAL) was the target of a large drop in short interest during the month of August. As of August 14th, there was short interest totaling 3,692,056 shares, a drop of 35.5% from the July 30th total of 5,720,042 shares. Based on an average daily volume of 1,479,843 shares, the short-interest ratio is presently 2.5 days. Currently, 3.4% of the company’s stock are short sold.

Ralliant Trading Up 1.0%

Shares of Ralliant stock opened at $61.61 on Thursday. The company’s fifty day simple moving average is $67.91 and its 200-day simple moving average is $56.92. The stock has a market capitalization of $6.82 billion, a PE ratio of -5.68, a P/E/G ratio of 2.27 and a beta of 1.54. Ralliant has a 1-year low of $37.27 and a 1-year high of $75.41. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts anticipate that Ralliant will post 2.87 earnings per share for the current year.

Ralliant Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Analysts Set New Price Targets

RAL has been the topic of a number of recent analyst reports. Morgan Stanley raised their price target on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Zacks Research upgraded shares of Ralliant from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Royal Bank Of Canada raised their target price on shares of Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a report on Friday, July 31st. Citigroup lifted their target price on shares of Ralliant from $81.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, Oppenheimer boosted their target price on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $75.70.

Insider Buying and Selling at Ralliant

In other news, SVP Karen M. Bick sold 6,062 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the transaction, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. This represents a 16.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the stock in a transaction on Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares in the company, valued at $18,088,710.93. This trade represents a 4.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.42% of the company’s stock.

Institutional Investors Weigh In On Ralliant

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RAL. Corient Private Wealth LP raised its position in shares of Ralliant by 41.2% during the 2nd quarter. Corient Private Wealth LP now owns 35,050 shares of the company’s stock valued at $2,581,000 after purchasing an additional 10,230 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Ralliant in the 2nd quarter worth $3,634,000. California State Teachers Retirement System increased its stake in Ralliant by 7,051.8% in the 2nd quarter. California State Teachers Retirement System now owns 9,356,090 shares of the company’s stock worth $688,889,000 after buying an additional 9,225,268 shares in the last quarter. Nykredit A S bought a new stake in Ralliant during the second quarter valued at about $219,000. Finally, B. Metzler seel. Sohn & Co. AG lifted its position in shares of Ralliant by 231.8% in the second quarter. B. Metzler seel. Sohn & Co. AG now owns 23,944 shares of the company’s stock valued at $1,763,000 after acquiring an additional 16,727 shares in the last quarter.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.